Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nicodrops is an all-natural, nicotine-free herbal lozenge developed by Nicodrops, Inc. as a smoking cessation aid. The product features a proprietary blend of herbal ingredients, including Ginseng, St. John's Wort, and Valerian, which are intended to calm the nervous system and mitigate the stress and cravings typically associated with quitting smoking. Classified as a herbal dietary supplement rather than a pharmaceutical drug, Nicodrops does not contain nicotine or synthetic pharmaceutical agents. It is notable for having received a Drug Identification Number (DIN 02245097) and a Natural Product Number (NPN 80060967) from Health Canada, although it has not been evaluated by the U.S. FDA for therapeutic claims.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nicodrops.